Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Small molecules for disrupting the super elongation complex and inhibiting transcription elongation for cancer therapy

Small molecules for disrupting the super elongation complex and inhibiting transcription elongation for cancer therapy

US Patent 11453640 · Granted Sep 27, 2022

Estimated economic value: $151,687,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhanc2025
Substituted [1,2,4]triazolo[4,3-c]pyrimidines that induce degradation of embryon2025
Bifunctional compounds comprising Apcin-A and their use in the treatment of canc2025
Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of in2025
Substituted fused pyrrolo-diazepinones and uses thereof2025
Substituted heterocycles as c-MYC targeting agents2024
Substituted heterocycles as c-MYC targeting agents2024
Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhanc2024
Substituted [1,2,4]triazolo[4,3-c]pyrimidin-5-amines and proteolysis-targeting c2024
Substituted pyrrolidones and piperidones as small molecule inhibitors of EZH2 an2024
GCN2 and perk kinase inhibitors and methods of use thereof2024
Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of c-2024